Fig. 2From: Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trialCumulative percentage of patients achieving TOF ratio ≥ 0.9 pooled across depth of block. The 50th and 90th percentile times, in minutes, are marked for the ABW and IBW pooled groups. A given patient’s results were censored if monitoring terminated or data became unreliableBack to article page